The following video is part of our "Motley Fool Conversations" series in which consumer goods editor and analyst Austin Smith and industrials editor and analyst Isaac Pino discuss topics across the investing world.
In today's edition, Austin discusses one dividend aristocrat that may be losing its crown: Abbott Laboratories. The company has been paying dividends for an amazing 40 years. However, the company is now planning to split into two companies, a medical device company and a pharmaceutical company. In the past, Standard and Poor's has kicked companies off the Dividend Aristocrat list after a spinoff, much like in 2008 when it kicked out Altria following its Philip Morris spinoff.
Editor's note: In the video, Austin says the Kraft spinoff occurred in 2008; it was actually 2007. The Fool regrets the error.
Austin Smith has no positions in the stocks mentioned above. Isaac Pino has no positions in the stocks mentioned above. The Motley Fool owns shares of Abbott Laboratories, Johnson & Johnson, Altria Group, and Philip Morris International. Motley Fool newsletter services recommend Johnson & Johnson and Philip Morris International. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.